[HTML] nih.gov

[HTML][HTML] Ibrutinib may impair serological responses to influenza vaccination

AP Douglas, JA Trubiano, I Barr, V Leung… - …, 2017 - ncbi.nlm.nih.gov
AP Douglas, JA Trubiano, I Barr, V Leung, MA Slavin, CS Tam
Haematologica, 2017•ncbi.nlm.nih.gov
CLL: chronic lymphocytic leukemia; WM: Waldenström macroglobulinemia; FCR:
fludarabine, cyclophosphamide, rituximab; N/A-not applicable; R: rituximab; HSCT:
hematopoietic stem cell trsansplantation; CHOP: cyclophosphamide, doxorubicin,
vincristine, prednisolone; VIC: ifosfamide, etoposide, carboplatin; CHEP: cyclophosphamide,
doxorubicin, etoposide, prednisolone; CVP: cyclophosphamide, vincristine, prednisolone;
ND: not determined; IVIg: intravenous immunogliobulins; Y: yes; N: no; URTI: upper …
CLL: chronic lymphocytic leukemia; WM: Waldenström macroglobulinemia; FCR: fludarabine, cyclophosphamide, rituximab; N/A-not applicable; R: rituximab; HSCT: hematopoietic stem cell trsansplantation; CHOP: cyclophosphamide, doxorubicin, vincristine, prednisolone; VIC: ifosfamide, etoposide, carboplatin; CHEP: cyclophosphamide, doxorubicin, etoposide, prednisolone; CVP: cyclophosphamide, vincristine, prednisolone; ND: not determined; IVIg: intravenous immunogliobulins; Y: yes; N: no; URTI: upper respiratory tract infection; Mx: managed.
ncbi.nlm.nih.gov
展开收起
被引用次数：93 相关文章 所有 7 个版本
以上显示的是最相近的搜索结果。 查看全部搜索结果